TETRA BIO-PHARMA WKN: A2ASQ8 ISIN: CA88166Y1007 Kürzel: TBP Forum: Aktien Thema: Hauptdiskussion

0,0000 USD
-90,00 %0,0000
21. Dec, 02:10:00 Uhr, Nasdaq OTC
Kommentare 1.502
G
Goldtiger10.0, 13.02.2023 23:55 Uhr
0
OTCPink… habe ich noch nie gehört
G
Goldtiger10.0, 13.02.2023 23:54 Uhr
0
MONTREAL, Feb. 10, 2023 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTC-PINK: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, today announced that its common shares began trading on the OTC Markets Group's OTCPink Market in the United States under the symbol "TBPMF" effective at the opening of trading on Friday, February 10, 2023 and will continue to trade on the Toronto Stock Exchange (the "TSX") under the ticker symbol "TBP". Existing U.S. shareholders of Tetra will now find common shares quoted on the OTCPink without any further action needed. The Pink Open Market provides brokers with a regulated platform for transparent trading and best execution. Brokers quote a wide **** of companies on this market, including foreign companies that limit their disclosure in the U.S., penny stocks and shells. To be eligible for quotation on the Pink Market, companies must comply with the requirements of Securities Exchange Act Rule 15c2-11, including providing current information to the investing public
G
Goldtiger10.0, 22.12.2022 19:17 Uhr
0
Tetra Bio-Pharma Inc. has provided its shareholders with another regulatory update on the Reduvo new drug submission (NDS). The last update was provided on November 18, 2022. On December 21, 2022, the Company received a second Clarification Request (Clarifax) from Health Canada regarding the product's Risk Management Plan, which is not atypical for a controlled substance drug. The Company will be submitting the response to Health Canada within the allowed timeframe. The Company cannot comment on Health Canada's response timelines. Questions/feedback from Health Canada are received as the review of the dossier progresses through different review streams.
Igor12
Igor12, 19.12.2022 17:30 Uhr
0
Ist das Ding tot hier
Mhe
Mhe, 01.12.2022 13:25 Uhr
0
https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2022/Tetra-Bio-Pharma-Provides-Update-on-Patent-Applications-for-Novel-Therapeutic-ARDS-003/default.aspx
Mhe
Mhe, 19.11.2022 8:43 Uhr
0
Hoffen und beten leute. Das kann es sein..!
Mhe
Mhe, 19.11.2022 8:42 Uhr
0
https://ir.tetrabiopharma.com/newsroom/press-releases/news-details/2022/Tetra-Bio-Pharma-Provides-Update-on-Its-REDUVO-New-Drug-Submission/default.aspx?fbclid=IwAR3weOn1_zfYwrnEjpo-ZGCCiJBEXG2uCfl6JbGc8yXmiHxSqaCSZSnNGss&mibextid=Zxz2cZ
G
Goldtiger10.0, 22.09.2022 23:23 Uhr
0
Langsam bleibt nichts mehr übrig 🙈
G
Goldtiger10.0, 06.09.2022 21:57 Uhr
0
Tetra Bio-Pharma Inc. has signed an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product, with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug.
G
Goldtiger10.0, 13.08.2022 23:56 Uhr
0
Zumindest neue Finanzmittel OTTAWA, ON, Aug. 11, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development, announced today that it has entered into a subscription agreement (the "Subscription Agreement") with Global Corporate Finance Opportunities 16 (the "Investor"), an investment vehicle advised by Alpha Blue Ocean Inc. ("ABO"), whereby Tetra has agreed to issue to the Investor (i) senior unsecured convertible debentures ("Debentures") in the aggregate principal amount of up to $6,000,000, and (ii) warrants ("Warrants") to purchase common shares ("Common Shares") in the capital of the Company (collectively, the "Offering").
G
Goldtiger10.0, 13.08.2022 11:37 Uhr
0
Mit mäßigem Erfolg 🙈
G
Goldtiger10.0, 11.08.2022 23:36 Uhr
0
Cannabis-derived drug developer, Tetra Bio-Pharma Inc. (TBP), shared positive preclinical results from live COVID-19 infection studies and a septic lung model. The company stated these independently researched studies observed ARDS-003 and its potential to increase survival rates following a COVID-19 infection in a “humanized” mouse model. According to the company, ARDS-003 is a new drug which contains, a potent substance from a type two cannabinoid receptor, onternabez, which is an important immune system target. Tetra stated ARDS-003 can help regulate acute systemic inflammation and prevent sepsis, lung dysfunction, and organ damage. Allegedly, the studies demonstrated that ARDS-003 decreases hyperinflammatory response and slows disease progression. On top of this, Tetra shared that when using a recent septic lung model ARDS-003 produced a significant reduction of systemic cytokine and chemokine release. Lung tissue was improved, peripheral immune hyperactivation was reduced, and there was an improvement in capillary perfusion in lung tissue compared to controls. The company’s research team has also developed an oral formulation of the drug for an immediate release that can be used over time and may work well alongside other treatements.
G
Goldtiger10.0, 11.08.2022 23:36 Uhr
0
Immerhin geht wieder etwas
r
roman1101, 09.07.2022 14:08 Uhr
0
Ich bin auch dabei. Habe vor einigen Monaten mein ansonsten eher konservatives Portfolio mit dieser "Gambling"-Aktie aufgeschmückt :)
G
Goldtiger10.0, 06.07.2022 22:32 Uhr
0
Ok, scheinbar niemand mehr. Ciao
G
Goldtiger10.0, 01.07.2022 22:45 Uhr
0
Trauerspiel, aber ich bin noch dabei 🥴 ein bisschen ruhig hier. Sonst noch jemand dabei ?
Meistdiskutiert
Thema
1 INTEL Hauptdiskussion +0,05 %
2 Brainchip Klassengruppe ±0,00 %
3 Dax Prognose -0,40 %
4 PROSIEBENSAT1 MEDIA Hauptdiskussion +0,10 %
5 Vulcan Energy Resources Hauptdiskussion ±0,00 %
6 Lilium Aktie -56,91 %
7 AFC ENERGY Hauptdiskussion +0,18 %
8 DRONESHIELD LTD Hauptdiskussion ±0,00 %
9 NIO INC.A S.ADR DL-,00025 Hauptdiskussion +0,06 %
10 ATOS Hauptdiskussion +4,76 %
Alle Diskussionen
Aktien
Thema
1 INTEL Hauptdiskussion +0,05 %
2 Brainchip Klassengruppe ±0,00 %
3 PROSIEBENSAT1 MEDIA Hauptdiskussion +0,10 %
4 Vulcan Energy Resources Hauptdiskussion ±0,00 %
5 Lilium Aktie -56,91 %
6 AFC ENERGY Hauptdiskussion +0,18 %
7 DRONESHIELD LTD Hauptdiskussion ±0,00 %
8 NIO INC.A S.ADR DL-,00025 Hauptdiskussion +0,06 %
9 ATOS Hauptdiskussion +4,76 %
10 TESLA MOTORS Hauptdiskussion +0,04 %
Alle Diskussionen